Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection

Authors: Yönem, A.1; Çakir, B.2; Güler, S.2; Azal, Ö.1; Çorakçi, A.1

Source: Diabetes, Obesity and Metabolism, Volume 3, Number 5, October 2001 , pp. 332-337(6)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Abstract:

SUMMARY Aims 

Foot infections and the subsequent amputation of a lower extremity are the most common cause of hospitalization among patients with diabetes mellitus. Although there are several reasons for susceptibility to infection in diabetic patients, white blood cell dysfunction is considered to be an important cause for this tendency. Granulocyte-colony stimulating factor (G-CSF) increases the release of neutrophils from the bone marrow and improves neutrophil functions. Based on this knowledge, the aim of the present study was to investigate the effects of addition of G-CSF to the treatment of foot infections in diabetic patients. Methods 

Thirty diabetic patients with foot infection were included in the study. Fifteen of the patients received standard treatment consisting of local wound care and antibiotics (standard goup), and the other 15 patients received G-CSF besides standard treatment (G-CSF group). The objectives of this study were to determine the time to resolution of infection, time to hospital discharge, need for surgical intervention, and the effects of G-CSF on phagocytosis and respiratory burst of neutrophils. Results 

Treatment with G-CSF led to significantly higher neutrophil counts on the 5th and 10th days, and at the end of treatment in the G-CSF treated group compared to the standard group. Respiratory burst of neutrophils increased significantly in both the G-CSF group (from 1.6 ± 0.3 to 2.3 ± 0.5, p = 0.001) and the standard group (from 2.0 ± 0.4 to 2.3 ± 0.4, p = 0.02) with treatment. But, while phagocytosis of neutrophils increased significantly in the G-CSF group (from 70.4 ± 2.0 to 74.5 ± 1.9, p = 0.004), it did not change significantly in the standard group (from 68.1 ± 0.2 to 69.4 ± 1.9, p = 0.3) with treatment. Duration of hospitalization (26.9 ± 2.0 vs. 28.3 days, p < 0.05), duration of parenteral antibiotic administration (22.9 ± 2.0 vs. 23.3 ± 1.9 days, p < 0.05), time to resolution of infection (23.6 ± 1.8 vs. 22.3 ± 1.7 days, p < 0.05), and need for amputation (13.3% vs. 20%, p > 0.05) were similar between the G-CSF and the standard groups. Conclusions 

Although G-CSF improves neutrophil function as well as increasing the absolute numbers, this improvement is not associated with shortening of duration of antibiotic administration, duration of hospital stay or need for amputation in diabetic foot infection.

Keywords: granulocyte-colony stimulating factor; diabetes mellitus; diabetic foot infection; respiratory burst; phagocytosis; polymorphonuclear leucocytes

Document Type: Research article

Affiliations: 1: Department of Endocrinology, Gülhane School of Medicine, Ankara, Turkey 2: Department of Endocrinology and Metabolism, Ankara Education and Research Hospital, Ankara, Turkey

Publication date: 2001-10-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page